A daily pill from drugmaker Eli Lilly has shown safety results comparable to the leading injectable GLP-1 drugs Mounjaro and ...

THURSDAY, April 17, 2025 (HealthDay News) -- Common medications like aspirin, ibuprofen, statins and beta blockers appear to ...

Tirzepatide (Mounjaro) launched in India in March 2025, promising new hope for diabetes and obesity treatment. An expert ...

The internet went abuzz with gossip after a viral picture of Jr NTR’s recent appearance left everyone spellbound. The actor ...

Together, turmeric and apple cider vinegar could have powerful health benefits. Learn how to incorporate this combo into your ...

Girls Next Door alum Kendra Wilkinson shared that she recently tried using a weight loss drug but quickly changed her mind, ...

The budget proposes a massive $20 billion cut for the NIH in 2026 — roughly a 40% reduction — and a sweeping consolidation, from 27 institutes and centers to just eight. Any final budget plan will ...

Learn about effective skincare routines for all skin types. Find expert tips and product recommendations to help you achieve ...

Researchers at Mass General Brigham found that by December 2023, over one-third of all new prescriptions for type 2 diabetes ...

Eli Lilly has seen positive results from a phase 3 trial of Orforglipron, the first-ever GLP-1 pill for weight loss and type ...

The drugmaker Lilly announced topline results of a clinical trial of a new pill in the same drug class as injectables like ...

Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with type 2 ...